Improving the stability of thiol–maleimide bioconjugates via the formation of a thiazine structure
Journal of Peptide Science · 2023-10 · 29 (10)
DOI: 10.1002/psc.3495 ↗At a glance
Journal article in Journal of Peptide Science, published online on 2023-05-02. Written by Isaiah N Gober and 2 co-authors. Institution: Research and Development Department, Bachem Americas, Inc., Torrance, CA, USA. Major MEDLINE topics: Sulfhydryl Compounds, Cysteine. Cited 15 times so far (Crossref); 21 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Linker stability is critically important for the efficacy and safety of peptide and protein conjugates used for biological applications. One common conjugation strategy, thiol–maleimide coupling, generates a succinimidyl thioether linker with limited stability under physiological conditions. We have shown in previous work that when a peptide with an N‐terminal cysteine is conjugated to a maleimide reagent, a thiazine structure is formed via a chemical rearrangement. Our preliminary work indicated that the thiazine linker has favorable stability. Here, we report the evaluation of a thiazine linker as an alternative to the widely used succinimidyl thioether linker for thiol–maleimide bioconjugation. The stability of the thiazine conjugate in comparison to the thioether conjugate was assessed across a broad pH range. Additionally, the propensity for retro‐Michael reaction and cross‐reactivity with other thiols was evaluated by treating conjugates in the presence of glutathione. The studies indicated that the thiazine linker degrades markedly slower than the thioether conjugate. In addition, the thiazine linker is over 20 times less susceptible to glutathione adduct formation. The NMR study of the thiazine structure confirmed that the formation of the thiazine linker is a stereoselective process that yields a single diastereomer. In summary, we propose the use of the thiazine linker obtained by conjugation of maleimide‐containing reagents with peptides or proteins presenting an N‐terminal cysteine as a novel approach for bioconjugation. The advantages of this approach are the formation of a linker with a well‐defined stereochemical configuration, increased stability at physiological pH, and a strongly reduced propensity for thiol exchange.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Research and Development Department, Bachem Americas, Inc., Torrance, CA, USA.
- CMC Development Group, Bachem Americas, Inc., Torrance, CA, USA.
ORCID profiles: Isaiah N Gober, Rahul Sharan, Matteo Villain
Cite
APA
Gober, I. N., Sharan, R., & Villain, M. (2023). Improving the stability of thiol–maleimide bioconjugates via the formation of a thiazine structure. Journal of Peptide Science, 29(10). https://doi.org/10.1002/psc.3495
Vancouver
Gober IN, Sharan R, Villain M. Improving the stability of thiol–maleimide bioconjugates via the formation of a thiazine structure. Journal of Peptide Science. 2023;29(10). doi:10.1002/psc.3495
BibTeX
@article{Gober2023,
author = {Gober, Isaiah N and Sharan, Rahul and Villain, Matteo},
title = {Improving the stability of thiol–maleimide bioconjugates via the formation of a thiazine structure},
journal = {Journal of Peptide Science},
year = {2023},
volume = {29},
number = {10},
doi = {10.1002/psc.3495}
}
EUVIMED